Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s disease

OBJECTIVE: The incidence of adverse events in myeloablative transplant protocols is high in refractory Crohn’s disease; this study used low doses of cyclophosphamide. Fourteen patients were submitted to non-myeloablative autologous hematopoietic stem cell transplantation. RESULTS: The average number...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, Milton Artur, Kaiser, Roberto Luiz, de Quadros, Luiz Gustavo, Piron-Ruiz, Lilian, Peña-Arciniegas, Tatiana, Faria, Mikaell Alexandre Gouvea, Siqueira, Rubens Camargo, Pirozzi, Flavio Fontes, Kaiser, Fernanda Soubhia Liedtke, Burt, Richard K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639601/
https://www.ncbi.nlm.nih.gov/pubmed/28985769
http://dx.doi.org/10.1186/s13104-017-2824-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639601/
https://www.ncbi.nlm.nih.gov/pubmed/28985769
http://dx.doi.org/10.1186/s13104-017-2824-1

Ejemplares similares